Your browser doesn't support javascript.
loading
Real-world performance of the new C3 Gore Excluder stent-graft: 1-year results from the European C3 module of the Global Registry for Endovascular Aortic Treatment (GREAT).
Verhoeven, E L G; Katsargyris, A; Bachoo, P; Larzon, T; Fisher, R; Ettles, D; Boyle, J R; Brunkwall, J; Böckler, D; Florek, H-J; Stella, A; Kasprzak, P; Verhagen, H; Riambau, V.
Affiliation
  • Verhoeven EL; Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany. Electronic address: Eric.Verhoeven@klinikum-nuernberg.de.
  • Katsargyris A; Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany.
  • Bachoo P; Department of Vascular Surgery, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Larzon T; Department of Cardiothoracic and Vascular Surgery, Örebro University Hospital, Örebro, Sweden.
  • Fisher R; Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, UK.
  • Ettles D; Department of Radiology, Hull Royal Infirmary, Hull, UK.
  • Boyle JR; Department of Vascular Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Brunkwall J; Department of Vascular and Endovascular Surgery, University Clinics, University of Cologne, Cologne, Germany.
  • Böckler D; Department of Vascular and Endovascular Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Florek HJ; Department of Vascular and Endovascular Surgery, Weisseritztal Kliniken, Freital, Germany.
  • Stella A; Vascular Surgery Department, University of Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.
  • Kasprzak P; Department of Surgery, Vascular Surgery and Endovascular Surgery, University Hospital, University of Regensburg, Germany.
  • Verhagen H; Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Riambau V; Vascular Surgery Division, Department of Cardiovascular Surgery, Thorax Institute, Hospital Clinic, University of Barcelona, Spain.
Eur J Vasc Endovasc Surg ; 48(2): 131-7, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24878234
ABSTRACT

OBJECTIVES:

The European C3 module of the Global Registry for Endovascular Aortic Treatment (GREAT) provides "real-world" outcomes for the new C3 Gore Excluder stent-graft, and evaluates the new deployment mechanism. This report presents the 1-year results from 400 patients enrolled in this registry.

METHODS:

Between August 2010 and December 2012, 400 patients (86.8% male, mean age 73.9 ± 7.8 years) from 13 European sites were enrolled in this registry. Patient demographics, treatment indication, case planning, operative details including repositioning and technical results, and clinical outcome were analyzed.

RESULTS:

Technical success was achieved in 396/400 (99%) patients. Two patients needed intraoperative open conversion, one for iliac rupture, the second because the stent-graft was pulled down during a cross-over catheterization in an angulated anatomy. Two patients required an unplanned chimney renal stent to treat partial coverage of the left renal artery because of upward displacement of the stent-graft. Graft repositioning occurred in 192/399 (48.1%) patients, most frequently for level readjustment with regard to the renal arteries, and less commonly for contralateral gate reorientation. Final intended position of the stent-graft below the renal arteries was achieved in 96.2% of patients. Thirty-day mortality was two (0.5%) patients. Early reintervention (≤30 days) was required in two (0.5%) patients. Mean follow-up duration was 15.9 ± 8.8 months (range 0-37 months). Late reintervention (>30 days) was required in 26 (6.5%) patients. Estimated freedom from reintervention at 1 year was 95.2% (95% CI 92.3-97%), and at 2 years 91.5% (95% CI 86.8-94.5%). Estimated patient survival at 1 year was 96% (95% CI 93.3-97.6%) and at 2 years 90.6% (95% CI 85.6-93.9%).

CONCLUSIONS:

Early real-world experience shows that the new C3 delivery system offers advantages in terms of device repositioning resulting in high deployment accuracy. Longer follow-up is required to confirm that this high deployment accuracy results in improved long-term durability.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Vessel Prosthesis / Stents / Aortic Aneurysm, Abdominal / Blood Vessel Prosthesis Implantation / Endovascular Procedures Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Eur J Vasc Endovasc Surg Journal subject: ANGIOLOGIA Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Vessel Prosthesis / Stents / Aortic Aneurysm, Abdominal / Blood Vessel Prosthesis Implantation / Endovascular Procedures Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Eur J Vasc Endovasc Surg Journal subject: ANGIOLOGIA Year: 2014 Document type: Article